Disease Discovery Suites
The Disease Discovery Suites are highly customized software workflows to help biomedical researches reveal genomic characteristics that play a role in the development of certain diseases.
AstridBio offers disease discovery suites to biomedical researchers who use top-down research approaches and high-throughput laboratory technologies such as next-generation sequencer, microarray or mass spectrometer.
After several years in the field of biomedical research our team realized that all projects are different with unique needs in research methodology, lab technology or software used for the project. Some diseases are more prevalent than the others. Certain genetic mutations can influence the phenotype of an organism with extremely high penetrance while the effect of the others can be extinguished by environmental factors or genetic regulators. AstridBio has aimed to find the common point of these projects and categorized them into four groups:
- Rare Disease Discovery Suite allows researchers to identify rare genetic variations in the background of certain diseases or clinical symptoms.
- Malignant Disease Discovery Suite helps identify and distinguish driver and passenger mutations in the evolution of malignant diseases.
- Chronic Disease Discovery Suite uncovers the roles of low-impact genetic factors in the aetiology of common, non-communicable disorders.
- Infectious Disease Discovery Suite aims to discover genetic changes of human pathogenic microorganisms, and supports metagenomic analysis of the microbiome of the human host.